For decades Cochlear, CSL and ResMed could do no wrong. Those days are over, and a battery of issues has investors ...

Cochlear’s shares have collapsed after the hearing implants behemoth again downgraded profit guidance by up to $170m on deteriorating global consumer sentiment and the Middle East conflict.

A major Australian medical company has suffered a $4.4b wipeout after slashing its earnings forecast, which drove its share price to a 10-year low.

Mr Howitt said the country needed to focus on boosting productivity and reiterated his plea to the federal government to increase the cap on research and development tax concessions. “As a global ...

Cochlear chief executive Dig Howitt says tax reform and measures to boost productivity should be an election issue, as his company took a hit from cost of living pressures in the US. Mr Howitt said ...